Senior insider sale
Chief Commercial Officer at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$2.7K
3.97K shares
What this filing means
GASKINS TAMMI L plans to sell 3.97K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $2.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/8/2025ACC: 0002061679-25-000004
Officer· Chief Commercial Officer
Since Feb 2026
3.97K
Shares to sell
$2.7K
Approx. market value
4K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
n/a
8/16/2023
4KTotal acquired4K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/16/2023 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements n/a | 4K | — |
| Total | 4K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.56K
Market value
$1.5K
5/16/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
1.41K
Market value
$1.2K
8/11/2025
Total
Units
3.97K
Value
$2.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/16/2025 | 2.56K | $1.5K | — | Completed |
| Planned — Approximate Date | ||||
8/11/2025 | 1.41K | $1.2K | Nasdaq | Planned |
| Total | 3.97K | $2.7K | ||